Icon

DELATESTRYL (nda009165)- (200MG/ML,200MG/ML)

TESTOSTERONE ENANTHATE ENDO PHARMS
200MG/ML,200MG/ML
No No
Expired Expired
None None
None No
DELATESTRYL® (Testosterone Enanthate Injection, USP)in male is indicated for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired), Hypogonadotropic hypogonadism (congenital or acquired), Delayed puberty. DELATESTRYL® (Testosterone Enanthate Injection, USP) may be used secondarily in women with advancing inoperable metastatic (skeletal) mammary cancer who are one to five years postmenopausal.
4 0 2
Total Other Developers None
Drugs with Suitability No
200MG/ML ** ** - 1 -
NDA Sales Available Total Generic Sales Available
No 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ************ ***** ************ (********), *.* *********** ******* *** ** **, */**/**, ******** ******, ****-***, ******** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** ****-*, **. **. ***, *** & ***, ******* *******, ********* ******, *******-**********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.